Commission Implementing Regulation (EU) 2024/821 of 8 March 2024 renewing the approval of the low-risk active substance hydrolysed proteins in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
| Amendments and corrections | |
|---|---|
| May 1, 2024 | Application - See Art 3 |
| March 31, 2024 | Entry into force - Date pub. +20 See Art 3 |
| Consolidated texts |
|---|